3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
INDUSTRY
2
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Recurrence
1
Multiple Myeloma
1
Genetic Diseases, Inborn
1
Interventions
Vinorelbine
4
Dexamethasone
4
Filgrastim
3
Vincristine
2
Peripheral Blood Stem Cell Transplantation
2
Granulocyte Colony-Stimulating Factor
2
Gemcitabine
2
Fenretinide
2
Etoposide
2
Cytarabine
2
Carmustine
2
Bortezomib
2
zanubrutinib
1
relatlimab
1
pomalidomide
1
pegaspargase
1
palbociclib
1
liposomal amphotericin B
1
ixazomib
1
irinotecan sucrosofate
1
interferon gamma-1b
1
interferon gamma, Cys(-3), Tyr(-2), Cys(-1)-
1
imetelstat
1
etoposide phosphate
1
elotuzumab
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
carfilzomib
1
auricularum
1
aldesleukin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Recurrence
×
Clinical Trials, Phase II as Topic
×
Clear all
NCT03683277
2025-02-19
IFM2014-01
Intergroupe Francophone du Myelome
Phase 2
Terminated
26 enrolled